Corbus Pharmaceuticals Holdings, Inc. (CRBP) Financial Statements (2024 and earlier)

Company Profile

Business Address 500 RIVER RIDGE DRIVE
NORWOOD, MA 02062
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2023
MRQ
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments59,19797,64785,43331,74941,74862,537
Cash and cash equivalents17,00325,00785,43331,74941,74862,537
Short-term investments42,19472,641    
Restricted cash and investments192192350  159
Prepaid expense     2,492 
Other undisclosed current assets7922,3656,2916,406 2,808
Total current assets:60,181100,20592,07538,15544,24065,505
Noncurrent Assets
Operating lease, right-of-use asset3,8844,6095,2495,819
Property, plant and equipment1,6142,3934,0685,0842,7051,433
Restricted cash and investments477477670   
Other noncurrent assets15546234854441
Total noncurrent assets:6,1317,52610,22010,9882,7491,473
TOTAL ASSETS:66,312107,730102,29549,14246,98966,978
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities8,17311,87629,38733,53916,1977,872
Accounts payable2,1741,7827,38111,0916,3453,130
Accrued liabilities5,99910,09322,00522,4489,8514,742
Debt2,7963,0937101,348394333
Deferred rent credit     36
Derivative instruments and hedges, liabilities37134797   
Contract with customer, liability1,463
Other undisclosed current liabilities1,6341,9051,004   
Total current liabilities:12,64017,00831,89834,88818,0898,205
Noncurrent Liabilities
Long-term debt and lease obligation 15,98421,59225,1228,097  
Long-term debt, excluding current maturities 15,98415,63618,029   
Liabilities, other than long-term debt4,69822  1,376990
Deferred revenue and credits990
Deferred rent credit     1,376
Other liabilities2222   0
Operating lease, liability4,6755,9567,0938,097
Other undisclosed noncurrent liabilities  (7,093)   
Total noncurrent liabilities:20,68221,61525,1228,0971,376990
Total liabilities:33,32238,62257,02042,98519,4659,195
Equity
Equity, attributable to parent32,99069,10845,2756,15827,52457,784
Common stock01310666
Additional paid in capital425,196418,892349,358198,975148,889123,476
Accumulated other comprehensive loss(126)(62)    
Accumulated deficit(392,081)(349,734)(304,093)(192,824)(121,370)(65,698)
Total equity:32,99069,10845,2756,15827,52457,784
TOTAL LIABILITIES AND EQUITY:66,312107,730102,29549,14246,98966,978

Income Statement (P&L) ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Revenues978823,93736,1444,8222,440
Gain (loss) on disposition of assets for financial service operations 97663(251)  
Gross profit: 978823,93736,1444,8222,440
Operating expenses(39,835)(56,871)(126,747)(113,248)(61,570)(35,003)
Other undisclosed operating loss (97)     
Operating loss:(39,835)(55,989)(122,810)(77,105)(56,748)(32,563)
Nonoperating income (expense)(2,511)10,34911,5415,6511,076141
Investment income, nonoperating    1,228  
Gain (loss), foreign currency transaction, before tax(427)(384)(450)(159)93(42)
Other nonoperating income (expense)(49)11,900 4,582  
Interest and debt expense(3,097)(2,709)(1,127)  (1)
Loss from continuing operations:(45,444)(48,349)(112,396)(71,454)(55,672)(32,422)
Loss before gain (loss) on sale of properties:(48,349)(112,396)(71,454)(55,672)(32,422)
Other undisclosed net income3,0972,709    
Net loss:(42,347)(45,640)(112,396)(71,454)(55,672)(32,422)
Other undisclosed net income attributable to parent   1,127  1
Net loss available to common stockholders, diluted:(42,347)(45,640)(111,269)(71,454)(55,672)(32,422)

Comprehensive Income ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Net loss:(42,347)(45,640)(112,396)(71,454)(55,672)(32,422)
Other comprehensive income (loss)(64)(62)    
Comprehensive loss, net of tax, attributable to parent:(42,411)(45,703)(112,396)(71,454)(55,672)(32,422)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: